The tumor microenvironment and how one could reverse immunosupression. By studying tumor and blood samples from patients treated with dendritic Cell vaccines, both by immuno-histological, biochemical and by genomic and transcriptome analyses, we try to develop novel prognostic and predictive biomarkers. Also an in vitro 3D-Skin model is built to systematically study tumor- microenvironment interactions including immune cell migration.
Technicians: Anne van Duffelen, Kiek Verrijp
Postdocs: Laia Querol Cano